Company: CWAN
Filing Date: 2025-12-22
Form Type: DEF 14A
Source: 0001866368-25-000037
Chunk: 2

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-12-22
Form: DEF 14A
Chunk 2
---
 unvested at the time of closing will continue to vest on the schedule that has been outlined in your grant letter,

ii. All PSUs that remain unvested at the time of closing will continue to vest on the schedule that has been outlined in the grant letter but solely based on the time-based conditions in your grant letter. Given our recent financial performance, the performance condition will be deemed achieved at the maximum 110% level.

iii. As your awards vest after closing, instead of receiving shares you will receive cash equal to $24.55 per share at the next payroll date following the vesting. Normal taxes will be withheld in the regular course.

c. What happens to vesting that is scheduled to occur prior to the closing of the transaction?

i. As the transaction is currently expected to close in the first half of 2026, awards that vest prior to close will vest normally as per the terms set forth in the grant letter.

d. What about the ESPP (Employee Stock Purchase Plan)?

i. If the transaction closes prior to the end of the current offering period (May 31 st ), then we will end the period early before closing, consistent with the plan rules. If the transaction closes after the current offering period, then it will continue for the full term, shares will be purchased per the existing plan, and we will not start a new offering period. Additional details and timing will be communicated at a future date.

ii. If you are a current participant, you will not be permitted to increase your current contribution amount.

iii. If you are not already a participant, you will not be permitted to start participating.

e. What about the merit increase because of the annual review process that is currently underway?

i. There is no change to the annual review process.

ii. The annual cash “merit increase” budget for the company is largely unchanged and we will follow our normal process.

iii. There is no change to the benefits plans because of this announcement. HR has continued to refine and normalize benefits across the company and that activity will continue.

f. Will we get a budget for equity grants in 2026?

i. The company had identified and communicated to certain individuals from the erstwhile Enfusion that they would receive a grant on Jan 1, 2026 – we will proceed with that grant.

ii. A similar grant was already completed for identified individuals from the erstwhile Beacon.

iii. Additionally, we will have a budget for new grants as a part of our annual review process. Given